
Ad Scientiam Announces Completion of Enrollment in the pivotal MS-DETECT Study
A significant milestone achieved with the completion of enrollment in MS-DETECT, one of the most ambitious digital biomarker trials conducted in MS PARIS, FRANCE, June 19, 2025 /EINPresswire.com/ -- Ad Scientiam, a MedTech company leader in …